Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Hydrogel-based Drug Delivery Device Market Insights, Forecast to 2030
Global Hydrogel-based Drug Delivery Device Market Insights, Forecast to 2030
Industry: Medical Devices & Consumables
Published Date: 2024-07-07
Pages: 192 Pages
Report ld: 3233762
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The US & Canada market for Hydrogel-based Drug Delivery Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Hydrogel-based Drug Delivery Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Hydrogel-based Drug Delivery Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Hydrogel-based Drug Delivery Device include AstraZeneca Plc., Columbia Laboratories Inc., Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDelivery Sciences International Inc., Indivior PLC, GSK Plc, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Hydrogel-based Drug Delivery Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Hydrogel-based Drug Delivery Device, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Hydrogel-based Drug Delivery Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hydrogel-based Drug Delivery Device sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Hydrogel-based Drug Delivery Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Hydrogel-based Drug Delivery Device sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AstraZeneca Plc., Columbia Laboratories Inc., Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDelivery Sciences International Inc., Indivior PLC, GSK Plc, etc.
MARKET SEGMENTATION
By Company
- AstraZeneca Plc.
- Columbia Laboratories Inc.
- Mylan
- Teva Pharmaceuticals USA Inc.
- Blairex Laboratories Inc.
- ARx LLC.
- Endo International plc
- BioDelivery Sciences International Inc.
- Indivior PLC
- GSK Plc
- Pfizer Inc.
- Aquestive Therapeutics Inc.
- ZIM LABORATORIES LIMITED
- IntelGenx Corp.
- NEXGEL
- Bliss GVS Pharma Ltd.
- Teika Pharmaceutical Co. Ltd.
- Medherant Limited
- Galderma
- Johnson & Johnson
- Bausch and Lomb
- Ferring B.V
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Oral
- Buccal
- Rectal
- Vaginal
- Other
Segment by Application
- Hospital
- Clinic
- Other
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Hydrogel-based Drug Delivery Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Hydrogel-based Drug Delivery Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hydrogel-based Drug Delivery Device sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Hydrogel-based Drug Delivery Device Product Introduction
1.2 Market by Type
1.2.1 Global Hydrogel-based Drug Delivery Device Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Buccal
1.2.4 Rectal
1.2.5 Vaginal
1.2.6 Other
1.3 Market by Application
1.3.1 Global Hydrogel-based Drug Delivery Device Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Hydrogel-based Drug Delivery Device Revenue Estimates and Forecasts 2019-2030
2.2 Global Hydrogel-based Drug Delivery Device Revenue by Region
2.2.1 Global Hydrogel-based Drug Delivery Device Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Hydrogel-based Drug Delivery Device Revenue by Region (2019-2024)
2.2.3 Global Hydrogel-based Drug Delivery Device Revenue by Region (2025-2030)
2.2.4 Global Hydrogel-based Drug Delivery Device Revenue Market Share by Region (2019-2030)
2.3 Global Hydrogel-based Drug Delivery Device Sales Estimates and Forecasts 2019-2030
2.4 Global Hydrogel-based Drug Delivery Device Sales by Region
2.4.1 Global Hydrogel-based Drug Delivery Device Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Hydrogel-based Drug Delivery Device Sales by Region (2019-2024)
2.4.3 Global Hydrogel-based Drug Delivery Device Sales by Region (2025-2030)
2.4.4 Global Hydrogel-based Drug Delivery Device Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Hydrogel-based Drug Delivery Device Sales by Manufacturers
3.1.1 Global Hydrogel-based Drug Delivery Device Sales by Manufacturers (2019-2024)
3.1.2 Global Hydrogel-based Drug Delivery Device Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hydrogel-based Drug Delivery Device in 2023
3.2 Global Hydrogel-based Drug Delivery Device Revenue by Manufacturers
3.2.1 Global Hydrogel-based Drug Delivery Device Revenue by Manufacturers (2019-2024)
3.2.2 Global Hydrogel-based Drug Delivery Device Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Hydrogel-based Drug Delivery Device Revenue in 2023
3.3 Global Key Players of Hydrogel-based Drug Delivery Device, Industry Ranking, 2021 VS 2022
3.4 Global Hydrogel-based Drug Delivery Device Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Hydrogel-based Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Product Offered and Application
3.8 Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hydrogel-based Drug Delivery Device Sales by Type
4.1.1 Global Hydrogel-based Drug Delivery Device Historical Sales by Type (2019-2024)
4.1.2 Global Hydrogel-based Drug Delivery Device Forecasted Sales by Type (2025-2030)
4.1.3 Global Hydrogel-based Drug Delivery Device Sales Market Share by Type (2019-2030)
4.2 Global Hydrogel-based Drug Delivery Device Revenue by Type
4.2.1 Global Hydrogel-based Drug Delivery Device Historical Revenue by Type (2019-2024)
4.2.2 Global Hydrogel-based Drug Delivery Device Forecasted Revenue by Type (2025-2030)
4.2.3 Global Hydrogel-based Drug Delivery Device Revenue Market Share by Type (2019-2030)
4.3 Global Hydrogel-based Drug Delivery Device Price by Type
4.3.1 Global Hydrogel-based Drug Delivery Device Price by Type (2019-2024)
4.3.2 Global Hydrogel-based Drug Delivery Device Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Hydrogel-based Drug Delivery Device Sales by Application
5.1.1 Global Hydrogel-based Drug Delivery Device Historical Sales by Application (2019-2024)
5.1.2 Global Hydrogel-based Drug Delivery Device Forecasted Sales by Application (2025-2030)
5.1.3 Global Hydrogel-based Drug Delivery Device Sales Market Share by Application (2019-2030)
5.2 Global Hydrogel-based Drug Delivery Device Revenue by Application
5.2.1 Global Hydrogel-based Drug Delivery Device Historical Revenue by Application (2019-2024)
5.2.2 Global Hydrogel-based Drug Delivery Device Forecasted Revenue by Application (2025-2030)
5.2.3 Global Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2019-2030)
5.3 Global Hydrogel-based Drug Delivery Device Price by Application
5.3.1 Global Hydrogel-based Drug Delivery Device Price by Application (2019-2024)
5.3.2 Global Hydrogel-based Drug Delivery Device Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Hydrogel-based Drug Delivery Device Market Size by Type
6.1.1 US & Canada Hydrogel-based Drug Delivery Device Sales by Type (2019-2030)
6.1.2 US & Canada Hydrogel-based Drug Delivery Device Revenue by Type (2019-2030)
6.2 US & Canada Hydrogel-based Drug Delivery Device Market Size by Application
6.2.1 US & Canada Hydrogel-based Drug Delivery Device Sales by Application (2019-2030)
6.2.2 US & Canada Hydrogel-based Drug Delivery Device Revenue by Application (2019-2030)
6.3 US & Canada Hydrogel-based Drug Delivery Device Market Size by Country
6.3.1 US & Canada Hydrogel-based Drug Delivery Device Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Hydrogel-based Drug Delivery Device Revenue by Country (2019-2030)
6.3.3 US & Canada Hydrogel-based Drug Delivery Device Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Hydrogel-based Drug Delivery Device Market Size by Type
7.1.1 Europe Hydrogel-based Drug Delivery Device Sales by Type (2019-2030)
7.1.2 Europe Hydrogel-based Drug Delivery Device Revenue by Type (2019-2030)
7.2 Europe Hydrogel-based Drug Delivery Device Market Size by Application
7.2.1 Europe Hydrogel-based Drug Delivery Device Sales by Application (2019-2030)
7.2.2 Europe Hydrogel-based Drug Delivery Device Revenue by Application (2019-2030)
7.3 Europe Hydrogel-based Drug Delivery Device Market Size by Country
7.3.1 Europe Hydrogel-based Drug Delivery Device Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Hydrogel-based Drug Delivery Device Revenue by Country (2019-2030)
7.3.3 Europe Hydrogel-based Drug Delivery Device Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Hydrogel-based Drug Delivery Device Market Size by Type
8.1.1 China Hydrogel-based Drug Delivery Device Sales by Type (2019-2030)
8.1.2 China Hydrogel-based Drug Delivery Device Revenue by Type (2019-2030)
8.2 China Hydrogel-based Drug Delivery Device Market Size by Application
8.2.1 China Hydrogel-based Drug Delivery Device Sales by Application (2019-2030)
8.2.2 China Hydrogel-based Drug Delivery Device Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Hydrogel-based Drug Delivery Device Market Size by Type
9.1.1 Asia Hydrogel-based Drug Delivery Device Sales by Type (2019-2030)
9.1.2 Asia Hydrogel-based Drug Delivery Device Revenue by Type (2019-2030)
9.2 Asia Hydrogel-based Drug Delivery Device Market Size by Application
9.2.1 Asia Hydrogel-based Drug Delivery Device Sales by Application (2019-2030)
9.2.2 Asia Hydrogel-based Drug Delivery Device Revenue by Application (2019-2030)
9.3 Asia Hydrogel-based Drug Delivery Device Market Size by Region
9.3.1 Asia Hydrogel-based Drug Delivery Device Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Hydrogel-based Drug Delivery Device Revenue by Region (2019-2030)
9.3.3 Asia Hydrogel-based Drug Delivery Device Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Market Size by Type
10.1.1 Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Market Size by Application
10.2.1 Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Market Size by Country
10.3.1 Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 AstraZeneca Plc.
11.1.1 AstraZeneca Plc. Company Information
11.1.2 AstraZeneca Plc. Overview
11.1.3 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Plc. Recent Developments
11.2 Columbia Laboratories Inc.
11.2.1 Columbia Laboratories Inc. Company Information
11.2.2 Columbia Laboratories Inc. Overview
11.2.3 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Columbia Laboratories Inc. Recent Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Overview
11.3.3 Mylan Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Mylan Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mylan Recent Developments
11.4 Teva Pharmaceuticals USA Inc.
11.4.1 Teva Pharmaceuticals USA Inc. Company Information
11.4.2 Teva Pharmaceuticals USA Inc. Overview
11.4.3 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Pharmaceuticals USA Inc. Recent Developments
11.5 Blairex Laboratories Inc.
11.5.1 Blairex Laboratories Inc. Company Information
11.5.2 Blairex Laboratories Inc. Overview
11.5.3 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Blairex Laboratories Inc. Recent Developments
11.6 ARx LLC.
11.6.1 ARx LLC. Company Information
11.6.2 ARx LLC. Overview
11.6.3 ARx LLC. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 ARx LLC. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 ARx LLC. Recent Developments
11.7 Endo International plc
11.7.1 Endo International plc Company Information
11.7.2 Endo International plc Overview
11.7.3 Endo International plc Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Endo International plc Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Endo International plc Recent Developments
11.8 BioDelivery Sciences International Inc.
11.8.1 BioDelivery Sciences International Inc. Company Information
11.8.2 BioDelivery Sciences International Inc. Overview
11.8.3 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BioDelivery Sciences International Inc. Recent Developments
11.9 Indivior PLC
11.9.1 Indivior PLC Company Information
11.9.2 Indivior PLC Overview
11.9.3 Indivior PLC Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Indivior PLC Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Indivior PLC Recent Developments
11.10 GSK Plc
11.10.1 GSK Plc Company Information
11.10.2 GSK Plc Overview
11.10.3 GSK Plc Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 GSK Plc Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GSK Plc Recent Developments
11.11 Pfizer Inc.
11.11.1 Pfizer Inc. Company Information
11.11.2 Pfizer Inc. Overview
11.11.3 Pfizer Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Pfizer Inc. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Pfizer Inc. Recent Developments
11.12 Aquestive Therapeutics Inc.
11.12.1 Aquestive Therapeutics Inc. Company Information
11.12.2 Aquestive Therapeutics Inc. Overview
11.12.3 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Aquestive Therapeutics Inc. Recent Developments
11.13 ZIM LABORATORIES LIMITED
11.13.1 ZIM LABORATORIES LIMITED Company Information
11.13.2 ZIM LABORATORIES LIMITED Overview
11.13.3 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 ZIM LABORATORIES LIMITED Recent Developments
11.14 IntelGenx Corp.
11.14.1 IntelGenx Corp. Company Information
11.14.2 IntelGenx Corp. Overview
11.14.3 IntelGenx Corp. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 IntelGenx Corp. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 IntelGenx Corp. Recent Developments
11.15 NEXGEL
11.15.1 NEXGEL Company Information
11.15.2 NEXGEL Overview
11.15.3 NEXGEL Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 NEXGEL Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 NEXGEL Recent Developments
11.16 Bliss GVS Pharma Ltd.
11.16.1 Bliss GVS Pharma Ltd. Company Information
11.16.2 Bliss GVS Pharma Ltd. Overview
11.16.3 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Bliss GVS Pharma Ltd. Recent Developments
11.17 Teika Pharmaceutical Co. Ltd.
11.17.1 Teika Pharmaceutical Co. Ltd. Company Information
11.17.2 Teika Pharmaceutical Co. Ltd. Overview
11.17.3 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Teika Pharmaceutical Co. Ltd. Recent Developments
11.18 Medherant Limited
11.18.1 Medherant Limited Company Information
11.18.2 Medherant Limited Overview
11.18.3 Medherant Limited Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.18.4 Medherant Limited Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Medherant Limited Recent Developments
11.19 Galderma
11.19.1 Galderma Company Information
11.19.2 Galderma Overview
11.19.3 Galderma Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.19.4 Galderma Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Galderma Recent Developments
11.20 Johnson & Johnson
11.20.1 Johnson & Johnson Company Information
11.20.2 Johnson & Johnson Overview
11.20.3 Johnson & Johnson Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.20.4 Johnson & Johnson Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Johnson & Johnson Recent Developments
11.21 Bausch and Lomb
11.21.1 Bausch and Lomb Company Information
11.21.2 Bausch and Lomb Overview
11.21.3 Bausch and Lomb Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.21.4 Bausch and Lomb Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Bausch and Lomb Recent Developments
11.22 Ferring B.V
11.22.1 Ferring B.V Company Information
11.22.2 Ferring B.V Overview
11.22.3 Ferring B.V Hydrogel-based Drug Delivery Device Sales, Price, Revenue and Gross Margin (2019-2024)
11.22.4 Ferring B.V Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Ferring B.V Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hydrogel-based Drug Delivery Device Industry Chain Analysis
12.2 Hydrogel-based Drug Delivery Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hydrogel-based Drug Delivery Device Production Mode & Process
12.4 Hydrogel-based Drug Delivery Device Sales and Marketing
12.4.1 Hydrogel-based Drug Delivery Device Sales Channels
12.4.2 Hydrogel-based Drug Delivery Device Distributors
12.5 Hydrogel-based Drug Delivery Device Customers
13 Hydrogel-based Drug Delivery Device Market Dynamics
13.1 Hydrogel-based Drug Delivery Device Industry Trends
13.2 Hydrogel-based Drug Delivery Device Market Drivers
13.3 Hydrogel-based Drug Delivery Device Market Challenges
13.4 Hydrogel-based Drug Delivery Device Market Restraints
14 Key Findings in the Global Hydrogel-based Drug Delivery Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Hydrogel-based Drug Delivery Device Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Buccal
Table 4. Major Manufacturers of Rectal
Table 5. Major Manufacturers of Vaginal
Table 6. Major Manufacturers of Other
Table 7. Global Hydrogel-based Drug Delivery Device Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 9. Global Hydrogel-based Drug Delivery Device Revenue by Region (2019-2024) & (US$ Million)
Table 10. Global Hydrogel-based Drug Delivery Device Revenue by Region (2025-2030) & (US$ Million)
Table 11. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Region (2019-2024)
Table 12. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Region (2025-2030)
Table 13. Global Hydrogel-based Drug Delivery Device Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Table 14. Global Hydrogel-based Drug Delivery Device Sales by Region (2019-2024) & (K Units)
Table 15. Global Hydrogel-based Drug Delivery Device Sales by Region (2025-2030) & (K Units)
Table 16. Global Hydrogel-based Drug Delivery Device Sales Market Share by Region (2019-2024)
Table 17. Global Hydrogel-based Drug Delivery Device Sales Market Share by Region (2025-2030)
Table 18. Global Hydrogel-based Drug Delivery Device Sales by Manufacturers (2019-2024) & (K Units)
Table 19. Global Hydrogel-based Drug Delivery Device Sales Share by Manufacturers (2019-2024)
Table 20. Global Hydrogel-based Drug Delivery Device Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 21. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Manufacturers (2019-2024)
Table 22. Global Key Players of Hydrogel-based Drug Delivery Device, Industry Ranking, 2021 VS 2022 VS 2023
Table 23. Hydrogel-based Drug Delivery Device Price by Manufacturers (2019-2024) & (US$/Unit)
Table 24. Global Hydrogel-based Drug Delivery Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Hydrogel-based Drug Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydrogel-based Drug Delivery Device as of 2023)
Table 26. Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Product Offered and Application
Table 28. Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Hydrogel-based Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 31. Global Hydrogel-based Drug Delivery Device Sales by Type (2025-2030) & (K Units)
Table 32. Global Hydrogel-based Drug Delivery Device Sales Share by Type (2019-2024)
Table 33. Global Hydrogel-based Drug Delivery Device Sales Share by Type (2025-2030)
Table 34. Global Hydrogel-based Drug Delivery Device Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Hydrogel-based Drug Delivery Device Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Hydrogel-based Drug Delivery Device Revenue Share by Type (2019-2024)
Table 37. Global Hydrogel-based Drug Delivery Device Revenue Share by Type (2025-2030)
Table 38. Hydrogel-based Drug Delivery Device Price by Type (2019-2024) & (US$/Unit)
Table 39. Global Hydrogel-based Drug Delivery Device Price Forecast by Type (2025-2030) & (US$/Unit)
Table 40. Global Hydrogel-based Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 41. Global Hydrogel-based Drug Delivery Device Sales by Application (2025-2030) & (K Units)
Table 42. Global Hydrogel-based Drug Delivery Device Sales Share by Application (2019-2024)
Table 43. Global Hydrogel-based Drug Delivery Device Sales Share by Application (2025-2030)
Table 44. Global Hydrogel-based Drug Delivery Device Revenue by Application (2019-2024) & (US$ Million)
Table 45. Global Hydrogel-based Drug Delivery Device Revenue by Application (2025-2030) & (US$ Million)
Table 46. Global Hydrogel-based Drug Delivery Device Revenue Share by Application (2019-2024)
Table 47. Global Hydrogel-based Drug Delivery Device Revenue Share by Application (2025-2030)
Table 48. Hydrogel-based Drug Delivery Device Price by Application (2019-2024) & (US$/Unit)
Table 49. Global Hydrogel-based Drug Delivery Device Price Forecast by Application (2025-2030) & (US$/Unit)
Table 50. US & Canada Hydrogel-based Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 51. US & Canada Hydrogel-based Drug Delivery Device Sales by Type (2025-2030) & (K Units)
Table 52. US & Canada Hydrogel-based Drug Delivery Device Revenue by Type (2019-2024) & (US$ Million)
Table 53. US & Canada Hydrogel-based Drug Delivery Device Revenue by Type (2025-2030) & (US$ Million)
Table 54. US & Canada Hydrogel-based Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 55. US & Canada Hydrogel-based Drug Delivery Device Sales by Application (2025-2030) & (K Units)
Table 56. US & Canada Hydrogel-based Drug Delivery Device Revenue by Application (2019-2024) & (US$ Million)
Table 57. US & Canada Hydrogel-based Drug Delivery Device Revenue by Application (2025-2030) & (US$ Million)
Table 58. US & Canada Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. US & Canada Hydrogel-based Drug Delivery Device Revenue by Country (2019-2024) & (US$ Million)
Table 60. US & Canada Hydrogel-based Drug Delivery Device Revenue by Country (2025-2030) & (US$ Million)
Table 61. US & Canada Hydrogel-based Drug Delivery Device Sales by Country (2019-2024) & (K Units)
Table 62. US & Canada Hydrogel-based Drug Delivery Device Sales by Country (2025-2030) & (K Units)
Table 63. Europe Hydrogel-based Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 64. Europe Hydrogel-based Drug Delivery Device Sales by Type (2025-2030) & (K Units)
Table 65. Europe Hydrogel-based Drug Delivery Device Revenue by Type (2019-2024) & (US$ Million)
Table 66. Europe Hydrogel-based Drug Delivery Device Revenue by Type (2025-2030) & (US$ Million)
Table 67. Europe Hydrogel-based Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 68. Europe Hydrogel-based Drug Delivery Device Sales by Application (2025-2030) & (K Units)
Table 69. Europe Hydrogel-based Drug Delivery Device Revenue by Application (2019-2024) & (US$ Million)
Table 70. Europe Hydrogel-based Drug Delivery Device Revenue by Application (2025-2030) & (US$ Million)
Table 71. Europe Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 72. Europe Hydrogel-based Drug Delivery Device Revenue by Country (2019-2024) & (US$ Million)
Table 73. Europe Hydrogel-based Drug Delivery Device Revenue by Country (2025-2030) & (US$ Million)
Table 74. Europe Hydrogel-based Drug Delivery Device Sales by Country (2019-2024) & (K Units)
Table 75. Europe Hydrogel-based Drug Delivery Device Sales by Country (2025-2030) & (K Units)
Table 76. China Hydrogel-based Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 77. China Hydrogel-based Drug Delivery Device Sales by Type (2025-2030) & (K Units)
Table 78. China Hydrogel-based Drug Delivery Device Revenue by Type (2019-2024) & (US$ Million)
Table 79. China Hydrogel-based Drug Delivery Device Revenue by Type (2025-2030) & (US$ Million)
Table 80. China Hydrogel-based Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 81. China Hydrogel-based Drug Delivery Device Sales by Application (2025-2030) & (K Units)
Table 82. China Hydrogel-based Drug Delivery Device Revenue by Application (2019-2024) & (US$ Million)
Table 83. China Hydrogel-based Drug Delivery Device Revenue by Application (2025-2030) & (US$ Million)
Table 84. Asia Hydrogel-based Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 85. Asia Hydrogel-based Drug Delivery Device Sales by Type (2025-2030) & (K Units)
Table 86. Asia Hydrogel-based Drug Delivery Device Revenue by Type (2019-2024) & (US$ Million)
Table 87. Asia Hydrogel-based Drug Delivery Device Revenue by Type (2025-2030) & (US$ Million)
Table 88. Asia Hydrogel-based Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 89. Asia Hydrogel-based Drug Delivery Device Sales by Application (2025-2030) & (K Units)
Table 90. Asia Hydrogel-based Drug Delivery Device Revenue by Application (2019-2024) & (US$ Million)
Table 91. Asia Hydrogel-based Drug Delivery Device Revenue by Application (2025-2030) & (US$ Million)
Table 92. Asia Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 93. Asia Hydrogel-based Drug Delivery Device Revenue by Region (2019-2024) & (US$ Million)
Table 94. Asia Hydrogel-based Drug Delivery Device Revenue by Region (2025-2030) & (US$ Million)
Table 95. Asia Hydrogel-based Drug Delivery Device Sales by Region (2019-2024) & (K Units)
Table 96. Asia Hydrogel-based Drug Delivery Device Sales by Region (2025-2030) & (K Units)
Table 97. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Sales by Type (2019-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Sales by Type (2025-2030) & (K Units)
Table 99. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue by Type (2019-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue by Type (2025-2030) & (US$ Million)
Table 101. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Sales by Application (2019-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Sales by Application (2025-2030) & (K Units)
Table 103. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue by Application (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue by Application (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 106. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue by Country (2019-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue by Country (2025-2030) & (US$ Million)
Table 108. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Sales by Country (2019-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Sales by Country (2025-2030) & (K Units)
Table 110. AstraZeneca Plc. Company Information
Table 111. AstraZeneca Plc. Description and Major Businesses
Table 112. AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. AstraZeneca Plc. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. AstraZeneca Plc. Recent Developments
Table 115. Columbia Laboratories Inc. Company Information
Table 116. Columbia Laboratories Inc. Description and Major Businesses
Table 117. Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Columbia Laboratories Inc. Recent Developments
Table 120. Mylan Company Information
Table 121. Mylan Description and Major Businesses
Table 122. Mylan Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Mylan Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Mylan Recent Developments
Table 125. Teva Pharmaceuticals USA Inc. Company Information
Table 126. Teva Pharmaceuticals USA Inc. Description and Major Businesses
Table 127. Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Teva Pharmaceuticals USA Inc. Recent Developments
Table 130. Blairex Laboratories Inc. Company Information
Table 131. Blairex Laboratories Inc. Description and Major Businesses
Table 132. Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Blairex Laboratories Inc. Recent Developments
Table 135. ARx LLC. Company Information
Table 136. ARx LLC. Description and Major Businesses
Table 137. ARx LLC. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. ARx LLC. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. ARx LLC. Recent Developments
Table 140. Endo International plc Company Information
Table 141. Endo International plc Description and Major Businesses
Table 142. Endo International plc Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Endo International plc Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Endo International plc Recent Developments
Table 145. BioDelivery Sciences International Inc. Company Information
Table 146. BioDelivery Sciences International Inc. Description and Major Businesses
Table 147. BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. BioDelivery Sciences International Inc. Recent Developments
Table 150. Indivior PLC Company Information
Table 151. Indivior PLC Description and Major Businesses
Table 152. Indivior PLC Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Indivior PLC Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Indivior PLC Recent Developments
Table 155. GSK Plc Company Information
Table 156. GSK Plc Description and Major Businesses
Table 157. GSK Plc Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. GSK Plc Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. GSK Plc Recent Developments
Table 160. Pfizer Inc. Company Information
Table 161. Pfizer Inc. Description and Major Businesses
Table 162. Pfizer Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Pfizer Inc. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Pfizer Inc. Recent Developments
Table 165. Aquestive Therapeutics Inc. Company Information
Table 166. Aquestive Therapeutics Inc. Description and Major Businesses
Table 167. Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Aquestive Therapeutics Inc. Recent Developments
Table 170. ZIM LABORATORIES LIMITED Company Information
Table 171. ZIM LABORATORIES LIMITED Description and Major Businesses
Table 172. ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. ZIM LABORATORIES LIMITED Recent Developments
Table 175. IntelGenx Corp. Company Information
Table 176. IntelGenx Corp. Description and Major Businesses
Table 177. IntelGenx Corp. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. IntelGenx Corp. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. IntelGenx Corp. Recent Developments
Table 180. NEXGEL Company Information
Table 181. NEXGEL Description and Major Businesses
Table 182. NEXGEL Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 183. NEXGEL Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. NEXGEL Recent Developments
Table 185. Bliss GVS Pharma Ltd. Company Information
Table 186. Bliss GVS Pharma Ltd. Description and Major Businesses
Table 187. Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 188. Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Bliss GVS Pharma Ltd. Recent Developments
Table 190. Teika Pharmaceutical Co. Ltd. Company Information
Table 191. Teika Pharmaceutical Co. Ltd. Description and Major Businesses
Table 192. Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 193. Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Teika Pharmaceutical Co. Ltd. Recent Developments
Table 195. Medherant Limited Company Information
Table 196. Medherant Limited Description and Major Businesses
Table 197. Medherant Limited Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 198. Medherant Limited Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Medherant Limited Recent Developments
Table 200. Galderma Company Information
Table 201. Galderma Description and Major Businesses
Table 202. Galderma Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 203. Galderma Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 204. Galderma Recent Developments
Table 205. Johnson & Johnson Company Information
Table 206. Johnson & Johnson Description and Major Businesses
Table 207. Johnson & Johnson Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 208. Johnson & Johnson Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 209. Johnson & Johnson Recent Developments
Table 210. Bausch and Lomb Company Information
Table 211. Bausch and Lomb Description and Major Businesses
Table 212. Bausch and Lomb Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 213. Bausch and Lomb Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 214. Bausch and Lomb Recent Developments
Table 215. Ferring B.V Company Information
Table 216. Ferring B.V Description and Major Businesses
Table 217. Ferring B.V Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 218. Ferring B.V Hydrogel-based Drug Delivery Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 219. Ferring B.V Recent Developments
Table 220. Key Raw Materials Lists
Table 221. Raw Materials Key Suppliers Lists
Table 222. Hydrogel-based Drug Delivery Device Distributors List
Table 223. Hydrogel-based Drug Delivery Device Customers List
Table 224. Hydrogel-based Drug Delivery Device Market Trends
Table 225. Hydrogel-based Drug Delivery Device Market Drivers
Table 226. Hydrogel-based Drug Delivery Device Market Challenges
Table 227. Hydrogel-based Drug Delivery Device Market Restraints
Table 228. Research Programs/Design for This Report
Table 229. Key Data Information from Secondary Sources
Table 230. Key Data Information from Primary Sources
List of Figures
Figure 1. Hydrogel-based Drug Delivery Device Product Picture
Figure 2. Global Hydrogel-based Drug Delivery Device Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Hydrogel-based Drug Delivery Device Market Share by Type: 2023 & 2030
Figure 4. Oral Product Picture
Figure 5. Buccal Product Picture
Figure 6. Rectal Product Picture
Figure 7. Vaginal Product Picture
Figure 8. Other Product Picture
Figure 9. Global Hydrogel-based Drug Delivery Device Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 10. Global Hydrogel-based Drug Delivery Device Market Share by Application: 2023 & 2030
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Other
Figure 14. Hydrogel-based Drug Delivery Device Report Years Considered
Figure 15. Global Hydrogel-based Drug Delivery Device Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 17. Global Hydrogel-based Drug Delivery Device Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 18. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 19. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Region (2019-2030)
Figure 20. Global Hydrogel-based Drug Delivery Device Sales (2019-2030) & (K Units)
Figure 21. Global Hydrogel-based Drug Delivery Device Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 22. Global Hydrogel-based Drug Delivery Device Sales Market Share by Region (2019-2030)
Figure 23. US & Canada Hydrogel-based Drug Delivery Device Sales YoY (2019-2030) & (K Units)
Figure 24. US & Canada Hydrogel-based Drug Delivery Device Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Europe Hydrogel-based Drug Delivery Device Sales YoY (2019-2030) & (K Units)
Figure 26. Europe Hydrogel-based Drug Delivery Device Revenue YoY (2019-2030) & (US$ Million)
Figure 27. China Hydrogel-based Drug Delivery Device Sales YoY (2019-2030) & (K Units)
Figure 28. China Hydrogel-based Drug Delivery Device Revenue YoY (2019-2030) & (US$ Million)
Figure 29. Asia (excluding China) Hydrogel-based Drug Delivery Device Sales YoY (2019-2030) & (K Units)
Figure 30. Asia (excluding China) Hydrogel-based Drug Delivery Device Revenue YoY (2019-2030) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Sales YoY (2019-2030) & (K Units)
Figure 32. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue YoY (2019-2030) & (US$ Million)
Figure 33. Global Hydrogel-based Drug Delivery Device Sales Share by Manufacturers (2023)
Figure 34. The Hydrogel-based Drug Delivery Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 35. Global Hydrogel-based Drug Delivery Device Revenue Share by Manufacturers (2023)
Figure 36. The Top 5 and 10 Largest Manufacturers of Hydrogel-based Drug Delivery Device in the World: Market Share by Hydrogel-based Drug Delivery Device Revenue in 2023
Figure 37. Global Hydrogel-based Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 38. Global Hydrogel-based Drug Delivery Device Sales Market Share by Type (2019-2030)
Figure 39. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Type (2019-2030)
Figure 40. Global Hydrogel-based Drug Delivery Device Sales Market Share by Application (2019-2030)
Figure 41. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2019-2030)
Figure 42. US & Canada Hydrogel-based Drug Delivery Device Sales Market Share by Type (2019-2030)
Figure 43. US & Canada Hydrogel-based Drug Delivery Device Revenue Market Share by Type (2019-2030)
Figure 44. US & Canada Hydrogel-based Drug Delivery Device Sales Market Share by Application (2019-2030)
Figure 45. US & Canada Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2019-2030)
Figure 46. US & Canada Hydrogel-based Drug Delivery Device Revenue Share by Country (2019-2030)
Figure 47. US & Canada Hydrogel-based Drug Delivery Device Sales Share by Country (2019-2030)
Figure 48. US Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 49. Canada Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 50. Europe Hydrogel-based Drug Delivery Device Sales Market Share by Type (2019-2030)
Figure 51. Europe Hydrogel-based Drug Delivery Device Revenue Market Share by Type (2019-2030)
Figure 52. Europe Hydrogel-based Drug Delivery Device Sales Market Share by Application (2019-2030)
Figure 53. Europe Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2019-2030)
Figure 54. Europe Hydrogel-based Drug Delivery Device Revenue Share by Country (2019-2030)
Figure 55. Europe Hydrogel-based Drug Delivery Device Sales Share by Country (2019-2030)
Figure 56. Germany Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 57. France Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 58. U.K. Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 59. Italy Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 60. Russia Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 61. China Hydrogel-based Drug Delivery Device Sales Market Share by Type (2019-2030)
Figure 62. China Hydrogel-based Drug Delivery Device Revenue Market Share by Type (2019-2030)
Figure 63. China Hydrogel-based Drug Delivery Device Sales Market Share by Application (2019-2030)
Figure 64. China Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2019-2030)
Figure 65. Asia Hydrogel-based Drug Delivery Device Sales Market Share by Type (2019-2030)
Figure 66. Asia Hydrogel-based Drug Delivery Device Revenue Market Share by Type (2019-2030)
Figure 67. Asia Hydrogel-based Drug Delivery Device Sales Market Share by Application (2019-2030)
Figure 68. Asia Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2019-2030)
Figure 69. Asia Hydrogel-based Drug Delivery Device Revenue Share by Region (2019-2030)
Figure 70. Asia Hydrogel-based Drug Delivery Device Sales Share by Region (2019-2030)
Figure 71. Japan Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 72. South Korea Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 73. China Taiwan Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 74. Southeast Asia Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 75. India Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 76. Australia Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Sales Market Share by Type (2019-2030)
Figure 78. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue Market Share by Type (2019-2030)
Figure 79. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Sales Market Share by Application (2019-2030)
Figure 80. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2019-2030)
Figure 81. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Revenue Share by Country (2019-2030)
Figure 82. Middle East, Africa and Latin America Hydrogel-based Drug Delivery Device Sales Share by Country (2019-2030)
Figure 83. Brazil Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 84. Mexico Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 85. Turkey Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 86. Israel Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 87. GCC Countries Hydrogel-based Drug Delivery Device Revenue (2019-2030) & (US$ Million)
Figure 88. Hydrogel-based Drug Delivery Device Value Chain
Figure 89. Hydrogel-based Drug Delivery Device Production Process
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Hydrogel-based Drug Delivery Device market?
The top companies in the global Hydrogel-based Drug Delivery Device market are AstraZeneca Plc.、Columbia Laboratories Inc.、Mylan.
Related Reports
Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 198
USD 4900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 119
USD 4250.00
(Single User License)
Hydrogel-based Drug Delivery Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 153
USD 3950.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Research Report 2026
The global Hydrogel-based Drug Delivery Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 140
USD 2900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 197
USD 4900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 117
USD 4250.00
(Single User License)
Hydrogel-based Drug Delivery Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 168
USD 3950.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Research Report 2025
The global market for Hydrogel-based Drug Delivery Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 112
USD 2900.00
(Single User License)
Global and United States Hydrogel-based Drug Delivery Device Market Report & Forecast 2024-2030
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published Date: 2024-07-07
Pages: 179
USD 4350.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Research Report 2024
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published Date: 2024-07-07
Pages: 109
USD 2900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 198
USD 4900.00 (Single User License)Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 119
USD 4250.00 (Single User License)Hydrogel-based Drug Delivery Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 153
USD 3950.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Research Report 2026
The global Hydrogel-based Drug Delivery Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 140
USD 2900.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 197
USD 4900.00 (Single User License)Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 117
USD 4250.00 (Single User License)Hydrogel-based Drug Delivery Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 168
USD 3950.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Research Report 2025
The global market for Hydrogel-based Drug Delivery Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 112
USD 2900.00 (Single User License)Global and United States Hydrogel-based Drug Delivery Device Market Report & Forecast 2024-2030
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published: 2024-07-07
Pages: 179
USD 4350.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Research Report 2024
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published: 2024-07-07
Pages: 109
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now